Raj Mani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Raj Mani has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Kittipan Rerkasem
Chiang Mai University
12 shared publications- Marco Romanelli
Department of Dermatology, University of Pisa, 56126 Pisa, Italy
2 shared publications - Mark Richardson
Independent Researcher, York, England
2 shared publications Shuliang Lu
Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsTing Xie
Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsAlberto Piaggesi
Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
1 shared publication
Latest Publications
- 25 October 2023
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 23 (1) , 55-62
Oxygen Saturation or Tissue Oxygen Determinations on Skin Whose Viability is at Risk
The triad of ischaemia, neuropathy, and infection are among the principal causes of lower extremity wounds that are commonly prevalent in patients with diabetic foot (DF) a condition in which peripheral arterial disease commonly co-exists. The prevalence of this condition is increasing globally and with it, the mounting costs of its management. One aspect of management is saving limbs and or digits, a crucial part of this process is assessing tissue viability of skin which is a focus of this review: there are other aspects which are well described in the literature. Amputations are offered to limit the damage resulting from acute/chronic ischaemia. Holstein measured skin perfusion pressure using a radioisotope clearance technique to describe critically ischaemic skin; he found 30 mm Hg as the threshold above which healing may reliably be expected. Recent advances in vascular surgery and related technology have informed evidence-based advice to revascularize and save limbs; in practice, this may leave a wound in the distal skin unhealed; managing these raises questions of tissue viability. Much effort has been made to manage, prevent and to better understand these lower extremity wounds using measurements of tissue oxygen, oxygen saturation and skin imaging. The measurement techniques and their relevant merits are examined in this article. Advances in wound management systems and protocols can also facilitate the repair processes, and those which can have a particular impact on restoring or maintaining tissue perfusion are also discussed in the article.
- 25 October 2023
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 23 (1) , 55-62
Oxygen Saturation or Tissue Oxygen Determinations on Skin Whose Viability is at Risk
The triad of ischaemia, neuropathy, and infection are among the principal causes of lower extremity wounds that are commonly prevalent in patients with diabetic foot (DF) a condition in which peripheral arterial disease commonly co-exists. The prevalence of this condition is increasing globally and with it, the mounting costs of its management. One aspect of management is saving limbs and or digits, a crucial part of this process is assessing tissue viability of skin which is a focus of this review: there are other aspects which are well described in the literature. Amputations are offered to limit the damage resulting from acute/chronic ischaemia. Holstein measured skin perfusion pressure using a radioisotope clearance technique to describe critically ischaemic skin; he found 30 mm Hg as the threshold above which healing may reliably be expected. Recent advances in vascular surgery and related technology have informed evidence-based advice to revascularize and save limbs; in practice, this may leave a wound in the distal skin unhealed; managing these raises questions of tissue viability. Much effort has been made to manage, prevent and to better understand these lower extremity wounds using measurements of tissue oxygen, oxygen saturation and skin imaging. The measurement techniques and their relevant merits are examined in this article. Advances in wound management systems and protocols can also facilitate the repair processes, and those which can have a particular impact on restoring or maintaining tissue perfusion are also discussed in the article.
- 11 August 2023
- Published by Elsevier in Clinical Biomechanics
- Vol. 108, 106066
Letter to the editor of clinical biomechanics
- 11 August 2023
- Published by Elsevier in Clinical Biomechanics
- Vol. 108, 106066
Letter to the editor of clinical biomechanics
- 28 April 2023
- Published by Springer Nature
- p. 1-6
Chronic Wound Management—A Continuing Challenge
- 28 April 2023
- Published by Springer Nature
- p. 7-43
The Role of Technology in Managing Vascular Wounds
- Open Access
Injectable nanoclay gels for angiogenesis
The retention and sustained activity of therapeutic proteins at delivery sites are goals of regenerative medicine. Vascular endothelial growth factor (VEGF) has significant potential in promoting the growth and regeneration of blood vessels but is intrinsically labile. This is exacerbated by the inflammatory microenvironments at sites requiring regeneration. For VEGF to be efficacious it may require a carrier that stabilises it, protects it from degradation and retains it at a site of interest. In this study we tested the hypothesis that injectable nanoclay gels composed of Laponite XLG can stabilise VEGF and retain it in active form for therapeutic delivery. To achieve this, VEGF was incorporated in Laponite gels and its activity tested at a range of concentrations using in vivo cell culture tubulogenesis assays and in vivo angiogenesis assays. We found that VEGF-Laponite gels enhanced tubulogenesis in a dose-dependent manner in vivo . When administered subcutaneously in vivo Laponite was retained at an injection site for up to a period of three weeks and promoted a 4-fold increase in blood vessel formation compared with alginate or vehicle controls as confirmed by CD31 staining. Notably, in contrast to alginate, Laponite gels did not release VEGF, indicating a strong interaction between the growth factor and the nanoclay, and suggesting that Laponite enhancement of VEGF efficacy is due to its retention at an implantation site over a prolonged period. Our approach provides a robust method for delivery of bioactive recombinant VEGF without the necessity for complex hydrogel or protein engineering.
Open AccessInjectable nanoclay gels for angiogenesis
The retention and sustained activity of therapeutic proteins at delivery sites are goals of regenerative medicine. Vascular endothelial growth factor (VEGF) has significant potential in promoting the growth and regeneration of blood vessels but is intrinsically labile. This is exacerbated by the inflammatory microenvironments at sites requiring regeneration. For VEGF to be efficacious it may require a carrier that stabilises it, protects it from degradation and retains it at a site of interest. In this study we tested the hypothesis that injectable nanoclay gels composed of Laponite XLG can stabilise VEGF and retain it in active form for therapeutic delivery. To achieve this, VEGF was incorporated in Laponite gels and its activity tested at a range of concentrations using in vivo cell culture tubulogenesis assays and in vivo angiogenesis assays. We found that VEGF-Laponite gels enhanced tubulogenesis in a dose-dependent manner in vivo . When administered subcutaneously in vivo Laponite was retained at an injection site for up to a period of three weeks and promoted a 4-fold increase in blood vessel formation compared with alginate or vehicle controls as confirmed by CD31 staining. Notably, in contrast to alginate, Laponite gels did not release VEGF, indicating a strong interaction between the growth factor and the nanoclay, and suggesting that Laponite enhancement of VEGF efficacy is due to its retention at an implantation site over a prolonged period. Our approach provides a robust method for delivery of bioactive recombinant VEGF without the necessity for complex hydrogel or protein engineering.
- Open Access
- 16 December 2018
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 17 (4) , 201-202
When Does Knowledge Turn Into Wisdom?
- 16 December 2018
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 17 (4) , 201-202
Open AccessWhen Does Knowledge Turn Into Wisdom?
- 11 December 2018
- Published by Springer Nature
- p. 185-197
Advances in Devices that Offer Lower Limb Compression
- 11 December 2018
- Published by Springer Nature
- p. 185-197
Advances in Devices that Offer Lower Limb Compression
- 11 December 2018
- Published by Springer Nature
- p. 1-11
The Public Health Burden of Chronic Wounds Needs a Whole Systems Approach
- 11 December 2018
- Published by Springer Nature
- p. 1-11
The Public Health Burden of Chronic Wounds Needs a Whole Systems Approach
- Open Access
- 1 June 2018
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 17 (2) , 69-70
Speed Against Fidelity of Communications: A Battle for Editors
- 1 June 2018
- Published by SAGE Publications in The International Journal of Lower Extremity Wounds
- Vol. 17 (2) , 69-70
Open AccessSpeed Against Fidelity of Communications: A Battle for Editors